Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2014.07.18, US 201462026336 P
ATSUTAKA MINAGAWA ET AL.: '3.iPS Saibo kara no Kogen Tokuiteki T-Saibo Yudo to Sono Rinsho Oyo' HEMATOLOGY FRONTIER vol. 24, no. 2, January 2014, pages 39 - 45, XP008185676 (B1)
US-A1- 2013 078 226 (B1)
HIROSHI KAWAMOTO ET AL.: 'Shokika ni yoru Kogen Tokuiteki T-Saibo no Cloning to Bank-ka Koso' REGENERATIVE MEDICINE vol. 13, no. SUPPL., January 2014, pages 176, SY-25 - 4, XP008185711 (B1)
HIROSHI KAWAMOTO: 'Application of the iPSC technology to immune cell therapy against cancer' CLINICAL ONCOLOGY vol. 12, no. 4, 2013, pages 450 - 459, XP008185663 (B1)
JP-A- 2006 306 822 (B1)
JURGENS LISA A. ET AL.: 'Transduction of Primary Lymphocytes with Epstein-Barr Virus (EBV) Latent Membrane Protein-Specific T- Cell Receptor Induces Lysis of Virus-Infected Cells: A Novel Strategy for the Treatment of Hodgkin's Disease and Nasopharyngeal Carcinoma' JOURNAL OF CLINICAL IMMUNOLOGY vol. 26, no. 1, 01 January 2006, pages 22 - 32, XP019281116 (B1)
KAWAMOTO HIROSHI ET AL.: 'Regeneration of antigen specific T cells using the iPSC technology: A novel strategy for cancer immunotherapy' THE 18TH JAPANESE ASSOCIATION OF CANCER IMMUNOLOGY SOKAI PROGRAM/SHOROKUSHU June 2014, page 50 3 (B1)
LEI FENGYANG ET AL.: 'Dual signals of TCR and Notch promote antigen-specific T cell development from pluripotent stem cells (P4370' THE JOURNAL OF IMMUNOLOGY vol. 190, no. 1, 2013, page 177 (B1)
LEI FENGYANG ET AL.: 'In Vivo Programming of Tumor Antigen-Specific T Lymphocytes from Pluripotent Stem Cells to Promote Cancer Immunosurveillance' CANCER RESEARCH vol. 71, no. 14, 15 July 2011, pages 4742 - 4747, XP055143834 DOI: 10.1158/0008-5472.CAN-11-0359 (B1)
MAY RENA J ET AL: "Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 13, no. 15 Pt 1, 1 August 2007 (2007-08-01), pages 4547-4555, XP002544528, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-07-0708 (B1)
OKA Y ET AL: "Cancer immunotherapy targeting Wilms' tumor gene WT1 product", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 164, 15 February 2000 (2000-02-15), pages 1873-1880, XP000890067, ISSN: 0022-1767 (B1)
RIOLOBOS LAURA ET AL.: 'HLA Engineering of Human Pluripotent Stem Cells' MOLECULAR THERAPY vol. 21, no. 6, 01 June 2013, pages 1232 - 1241, XP055145726 DOI: 10.1038/MT.2013.59 (B1)
TAKUYA MAEDA ET AL.: 'iPS Saibo Gijutsu o Mochiita Gan Kogen Tokuiteki T-Saibo no Saisei' REGENERATIVE MEDICINE vol. 13, no. SUPPL., January 2014, pages 226, O-29 - 2, XP008185842 (B1)
TAMANAKA TAICHI ET AL.: 'Recognition of a Natural WT1 Epitope by a Modified WT1 Peptide- specific T- Cell Receptor' ANTICANCER RESEARCH vol. 32, no. 12, 01 January 2012, pages 5201 - 5210, XP055386117 (B1)
THEMELI MARIA ET AL.: 'Generation of tumor- targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy' NATURE BIOTECHNOLOGY vol. 31, no. 10, 01 October 2013, pages 928 - 933, XP055143283 DOI: 10.1038/NBT.2678 (B1)
US-A1- 2009 217 403 (B1)
ATSUTAKA MINAGAWA ET AL.: 'Genome Edit o Riyo shita, iPS Saibo yori no Kogen Tokuiteki T- Saibo no Saisei' THE 18TH JAPANESE ASSOCIATION OF CANCER IMMUNOLOGY SOKAI PROGRAM/SHOROKUSHU June 2014, pages 161, Q19 - 3, XP008185843 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP3170896)
|
Innkommende, AR378322224
Korrespondanse (Hovedbrev inn)
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3170896)
|
Utgående
EP defect letter
|
Innkommende, AR375043281
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 10. avg. år (EP) | 2024.06.24 | 4160 | ZACCO NORWAY AS | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2023.06.06 | 2850 | ZACCO NORWAY AS | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2022.05.16 | 2550 | ZACCO NORWAY AS | Betalt og godkjent |
Årsavgift 7. avg. år (EP) | 2021.07.02 | 2200 | ZACCO NORWAY AS | Betalt og godkjent |
Forsinkelsesavgift patent | 2020.09.29 | 700 | TANDBERG INNOVATION AS | Betalt og godkjent |
Årsavgift 6. avg. år (EP) | 2020.09.29 | 2000 | TANDBERG INNOVATION AS | Betalt og godkjent |
32008108 expand_more expand_less | 2020.06.30 | 5500 | TANDBERG INNOVATION AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|